Modified allergens and their potential to treat allergic disease.

Modified allergens and their potential to treat allergic disease.

Item
http://www.wikidata.org/entity/Q38255585
Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients.Standardization and Regulation of Allergen Products in the European Union.Clinical use of adjuvants in allergen-immunotherapy.Immunomodulating peptides for food allergy prevention and treatment.Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities.Combination of specific allergen and probiotics induces specific regulatory B cells and enhances specific immunotherapy effect on allergic rhinitisSubcutaneous versus sublingual immunotherapy.A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up report.Novel strategies in immunotherapy for allergic diseases.
P2860

Modified allergens and their potential to treat allergic disease.

Item
http://www.wikidata.org/entity/Q38255585
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Modified allergens and their potential to treat allergic disease.
@en
type
label
Modified allergens and their potential to treat allergic disease.
@en
prefLabel
Modified allergens and their potential to treat allergic disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Modified allergens and their potential to treat allergic disease.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698